Compare Keysight Technologies Inc (KEYS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Revvity Inc — how do they compare? Keysight Technologies Inc trades at $329.98 (market cap $53.68B), while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Keysight Technologies Inc is far larger — about 4.5× Revvity Inc's market cap, and Revvity Inc pays a 0.26% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals.
| KEYS | RVTY | |
|---|---|---|
Market Cap | $53.68B | $11.87B |
Sector | Technology | Technology |
52-Week High | $373.34 | $117.75 |
52-Week Low | $158.51 | $82.26 |
Enterprise Value | $54.03B | $14.36B |
Dividend Yield | — | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $328.11, up 3.87% today, with strong earnings beats in recent quarters. The stock shows a bearish technical signal despite positive analyst sentiment, with 81% buy ratings and a $396.56 consensus price target. Recent developments include partnerships with the European Space Agency and acquisitions in photonics design, positioning the company for growth in 5G and AI-driven markets.
Outlook remains positive due to robust fundamentals and strategic expansions, but high valuation multiples and technical weakness pose risks. Revenue is projected to grow to $6.1B in 2026, with net income margin improving to 17.31%. Investors should weigh strong profitability against elevated P/E of 50.58 and current bearish momentum.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
